William Pao

William Pao, MD, PhD, is a distinguished medical professional with extensive experience in oncology and pharmacology. Currently, Pao serves as a Non Executive Board Member at Immunocore and an Adjunct Professor of Pharmacology and Medicine at Joan & Sanford I. Weill Medical College of Cornell University. As the Chief Executive Officer of Revelio Therapeutics, Inc., Pao focuses on advancing novel tumor-specific biologics for cancer treatment. Additional roles include serving as an Independent Member on the Board of Directors for Alentis Therapeutics and previously for Obsidian Therapeutics, along with being a Member of the Council of Visitors at Vanderbilt University School of Medicine and an Adjunct Professor of Medicine at Vanderbilt University Medical Center. Pao has held key positions in prominent companies including Chief Development Officer at Pfizer and Head of Pharma Research and Early Development at Roche. William's educational background includes a Doctor of Medicine from Yale School of Medicine, a Doctor of Philosophy in Biology from Yale University, and a Bachelor's degree in East Asian Studies from Harvard University.